Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT04225871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.
Study identification
- NCT ID
- NCT04225871
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 22, 2019
- Primary completion
- Jul 30, 2026
- Completion
- Jul 30, 2026
- Last update posted
- Aug 11, 2026
2019 – 2026
United States locations
- U.S. sites
- 33
- U.S. states
- 24
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mg0011 41 | Mobile | Alabama | 36604 | — |
| Mg0011 116 | Phoenix | Arizona | 85028 | — |
| Mg0011 31 | Irvine | California | 92697 | — |
| MG0011 4 | Los Angeles | California | 90033 | — |
| Mg0011 220 | Pasadena | California | 91101 | — |
| Mg0011 160 | San Francisco | California | 94115 | — |
| Mg0011 24 | New Haven | Connecticut | 06511 | — |
| Mg0011 27 | Washington D.C. | District of Columbia | 20052 | — |
| Mg0011 25 | Tampa | Florida | 33612 | — |
| Mg0011 135 | Augusta | Georgia | 30912 | — |
| Mg0011 188 | Glenview | Illinois | 60026-1339 | — |
| Mg0011 156 | Indianapolis | Indiana | 46202 | — |
| Mg0011 32 | Kansas City | Kansas | 66160 | — |
| Mg0011 33 | Detroit | Michigan | 48201 | — |
| Mg0011 49 | East Lansing | Michigan | 48824 | — |
| Mg0011 134 | Columbia | Missouri | 65201 | — |
| Mg0011 117 | Las Vegas | Nevada | 89145 | — |
| Mg0011 30 | Buffalo | New York | 14202-1102 | — |
| Mg0011 123 | Great Neck | New York | 11021 | — |
| Mg0011 23 | New York | New York | 10021 | — |
| Mg0011 47 | New York | New York | 10029 | — |
| Mg0011 22 | Chapel Hill | North Carolina | 27599 | — |
| Mg0011 122 | Cleveland | Ohio | 44195 | — |
| Mg0011 38 | Columbus | Ohio | 43210 | — |
| Mg0011 40 | Pittsburgh | Pennsylvania | 15212 | — |
| Mg0011 128 | Charleston | South Carolina | 29425-8908 | — |
| Mg0011 28 | Cordova | Tennessee | 38018 | — |
| Mg0011 131 | Austin | Texas | 78759 | — |
| Mg0011 19 | Dallas | Texas | 75390 | — |
| Mg0011 39 | Salt Lake City | Utah | 84105 | — |
| Mg0011 164 | Charlottesville | Virginia | 22903 | — |
| Mg0011 154 | Seattle | Washington | 98195 | — |
| Mg0011 45 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04225871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04225871 live on ClinicalTrials.gov.